Definium Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Definium Therapeutics, Inc. (DFTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 167.32 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 162.60K shares, a 45.26% increase year-over-year.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 4.72K shares, a 98.78% decline year-over-year.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 88.66K shares, a 9620.94% increase year-over-year.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 3.68K shares, a 92.17% decline year-over-year.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 589.91K shares, a 96.00% increase from fiscal 2024.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 300.97K shares, a 587.15% increase from fiscal 2023.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 43.80K shares, a 83.30% decline from fiscal 2022.
- Definium Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 262.25K shares, a 93.96% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 162.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 167.32K shares 10-Q · filed 2026-08-06 | 255.97K shares derived: sum of 3 quarters · filed 2026-08-06 | 259.66K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 4.72K shares 10-Q · filed 2026-05-07 | 93.37K shares derived: sum of 2 quarters · filed 2026-05-07 | 97.06K shares derived: sum of 3 quarters · filed 2026-05-07 | 209.00K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 88.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 92.34K shares derived: sum of 2 quarters · filed 2026-02-26 | 204.28K shares derived: sum of 3 quarters · filed 2026-02-26 | 589.91K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 3.68K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 115.62K shares derived: sum of 2 quarters · filed 2025-11-06 | 501.25K shares 10-Q · filed 2025-11-06 | 502.16K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 111.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | 497.57K shares 10-Q · filed 2025-07-31 | 498.48K shares derived: sum of 3 quarters · filed 2025-07-31 | 545.50K shares derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | 385.63K shares 10-Q · filed 2025-05-08 | 386.54K shares derived: sum of 2 quarters · filed 2025-05-08 | 433.56K shares derived: sum of 3 quarters · filed 2025-05-08 | 636.05K shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 912.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 47.93K shares derived: sum of 2 quarters · filed 2025-03-06 | 250.43K shares derived: sum of 3 quarters · filed 2025-03-06 | 300.97K shares 10-K · filed 2025-03-06 |
| 2024-09-30 | 47.02K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 249.51K shares derived: sum of 2 quarters · filed 2024-11-07 | 300.06K shares 10-Q · filed 2024-11-07 | 322.61K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 202.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 253.04K shares 10-Q · filed 2024-08-13 | 275.60K shares derived: sum of 3 quarters · filed 2024-08-13 | 286.71K shares derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | 50.55K shares 10-Q · filed 2024-05-08 | 73.10K shares derived: sum of 2 quarters · filed 2024-05-08 | 84.21K shares derived: sum of 3 quarters · filed 2024-05-08 | |
| 2023-12-31 | 22.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 33.66K shares derived: sum of 2 quarters · filed 2024-02-28 | 43.80K shares 10-K · filed 2024-02-28 | |
| 2023-09-30 | 11.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | 21.25K shares 10-Q · filed 2023-11-02 | ||
| 2023-06-30 | 10.14K shares 10-Q · filed 2023-08-03 | |||
| 2022-12-31 | 214.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -403.98K shares derived: sum of 2 quarters · filed 2023-03-09 | 78.77K shares derived: sum of 3 quarters · filed 2023-03-09 | 262.25K shares 10-K · filed 2023-03-09 |
| 2022-09-30 | -618.81K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -136.06K shares derived: sum of 2 quarters · filed 2022-11-10 | 47.42K shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 482.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 666.23K shares 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | 183.48K shares 10-Q · filed 2022-05-16 | |||
| 2021-12-31 | 4.34M shares 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |